Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
Clinical trial NCT05532813 · RECRUITING
Trial details
- NCT number
- NCT05532813
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-29
- Primary completion
- 2026-11-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.